Sign up
Quantellect · Congress · Trade Detail
BIVVBioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthur
RepublicanHouse

Thomas MacArthur sold Bioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthur (BIVV)

Thomas MacArthur (R-NJ), a U.S. Representative, has disclosed 6 trades in Bioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthur (BIVV) since 2017, 3 purchases and 3 sales, worth an estimated $73K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Thomas MacArthur sold $1,001 - $15,000 of Bioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthur (BIVV) on January 22, 2018. Since that trade, BIVV is up +0.00% against the S&P 500 up +193.18%, an outperformance of -193.18%.

Across these filings, Thomas MacArthur has been a balanced trader of BIVV (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

BIVV trades
6
Disclosed Vol
$73K
Buys
3
50%
Sells
3
50%
Buy / Sell
1.00
ratio
First → Last
2017–2018

Thomas MacArthur's BIVV trades vs the price

BIVV is up +0.00% since Thomas MacArthur sold on January 22, 2018, versus +193.18% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+193.18%
Outperformance vs S&P 500
-193.18%

All Thomas MacArthur BIVV trades

TradedTypeSizeReturnEst. profit
January 22, 2018SELL$15,001 - $50,000N/A
January 22, 2018SELL$1,001 - $15,000N/A
January 22, 2018SELL$1,001 - $15,000N/A
February 2, 2017BUY$1,001 - $15,000N/A
February 2, 2017BUY$1,001 - $15,000N/A
February 2, 2017BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Thomas MacArthur & BIVV trading FAQ

Is it legal for Thomas MacArthur to trade Bioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthur (BIVV) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Bioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthur (BIVV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Thomas MacArthur sell BIVV?

Thomas MacArthur disclosed a sale of $1,001 - $15,000 of Bioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthur (BIVV) on January 22, 2018, according to public STOCK Act filings.

How has BIVV performed since Thomas MacArthur's trade?

Since Thomas MacArthur sold BIVV on January 22, 2018, the stock is up +0.00%, versus +193.18% for the S&P 500 over the same period, an outperformance of -193.18%.

How many times has Thomas MacArthur traded BIVV?

Thomas MacArthur has disclosed 6 BIVV trades since 2017 (3 purchases and 3 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional BIVV trades?

Quantellect tracks every disclosed congressional trade in Bioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthur (BIVV) on the Bioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthur congressional trading page, which aggregates filings across all members of Congress.

Thomas MacArthur's BIVV tradesAll congressional filings for Bioverativ Inc. (BIVV) F ILINg S TATUS : New S UBHoLDINg o F : MacArthur Family 2008 Irr Tr FBo David MacArthurThomas MacArthur's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.